insights_auto
Why is AQB up 13.21%?
Dive Deeperchevron_right
AQB:NASDAQ
Aquabounty Technologies Inc
$0.93
arrow_upward
+13.21%(+0.11) 1D
$0.92
arrow_downward
-1.69% (-0.016)bedtimeAfter hours
Closed: Nov 18, 4:00:00 PM GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for AQB...
Open
$0.79
High
$0.97
Low
$0.76
Mkt. cap
12.35M
Avg. vol.
167.45K
Volume
171.78K
52-wk high
$1.64
52-wk low
$0.71
EPS
-$4.51
Beta
1.45
Shares outstanding
13.29M
No. of employees
3
Open
$0.79
High
$0.97
Low
$0.76
Mkt. cap
12.35M
Avg. vol.
167.45K
Volume
171.78K
52-wk high
$1.64
52-wk low
$0.71
EPS
-$4.51
Beta
1.45
Shares outstanding
13.29M
No. of employees
3
News stories
From web sources and news partners
FXStreet
·
3 hours ago
Dow Jones Industrial Average drops as UnitedHealth and Nvidia fall
BeInCrypto
·
4 hours ago
S&P 500 Breaks Critical Support: Is a Bigger Stock Market Crash Coming?
ChartMill
·
3 hours ago
S&P 500 Postmarket Gainers: PANW, CRWD and OKTA Extend After-Hours Gains
Traders Union
·
3 hours ago
Peter Tuchman: S&P 500 loses $2.5 trillion in market cap over five days
Profile
AquaBounty Technologies is a biotechnology and aquaculture company based in Maynard, Massachusetts, United States. The company is notable for its research and development of genetically modified fish. It aims to create products that aim to increase the productivity of aquaculture. As of 2020, sale of the company's AquAdvantage salmon has been approved in Canada and the United States. The company sold all of its operating farms and ceased fish production in 2024. Wikipedia
About Aquabounty Technologies Inc
CEO-
Employees3
Founded1991
HeadquartersHarvard, Massachusetts, United States
SectorHealth Care
IndustryBiotechnology
Websiteaquabounty.com